Microbiota and Obesity: Where Are We Now?

Area of Science:

• Microbiome research
• Metabolic disease
• Obesity research

Background:

• Obesity and metabolic diseases stem from complex genetic and environmental factors, complicating treatment development.
• The gut and oral microbiota are increasingly recognized as critical contributors to these pathologies, though mechanisms remain unclear.
• Detailed understanding of microbiota structure, including composition, relationships, and metabolic functions, is crucial for combating obesity.

Purpose of the Study:

• To review the role of the microbiota in host energy homeostasis and obesity-related metabolic diseases.
• To explore the therapeutic potential of manipulating the microbiota for treating metabolic diseases and obesity.
• To discuss strategies such as dietary modulation and fecal microbiota transplantation.

Main Methods:

• Topical review of existing scientific literature.
• Analysis of the impact of nutrition and dietary modulation on the gut microbiota.
• Evaluation of fecal microbiota transplantation as a therapeutic strategy.

Main Results:

• The microbiota significantly influences host energy balance and the development of metabolic diseases.
• Identifying key bacterial species can enable the creation of a 'healthy' bacteria database for targeted interventions.
• Microbiota-targeted therapies offer a promising avenue for obesity treatment and management.

Conclusions:

• Targeting the gut microbiota is a viable clinical strategy for obesity and associated metabolic complications.
• Further research into microbiota composition and function will facilitate personalized therapeutic approaches.
• Dietary interventions and fecal microbiota transplantation show potential for modulating the microbiota to improve metabolic health.